 |
市場調查報告書
商品編碼
1567215
細胞凋亡市場：按應用、按方式、按最終用戶、按地區Apoptosis Market, By Application, By Modality, By End User, By Geography |
||||||
預計2024年全球細胞凋亡市場規模為38.1億美元，預計到2031年將達到56.5億美元，2024年至2031年的複合年成長率為5.8%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 38.1億美元 |
| 實際資料 | 2019年至2023年 | 預測期 | 從2024年到2031年 |
| 預測 2024-2031 年複合年成長率： | 5.80% | 2031年價值預測 | 56.5億美元 |
細胞凋亡，通常稱為程序性細胞死亡，是活生物體中的一種自然過程，以受控方式去除不需要或受損的細胞。細胞凋亡失調可導致癌症、自體免疫疾病和神經退化性疾病等病理狀況。因此，研究和開發調節細胞凋亡的新標靶治療療法來治療此類疾病正在促進該市場的成長。細胞凋亡分子機制的闡明和新型途徑抑制劑的開發取得的進展擴大了它們的應用，並增加了全世界對細胞凋亡調節藥物的需求。
市場動態：
癌症和其他細胞凋亡相關疾病盛行率的上升、製藥公司研發投資的增加以及美國食品和藥物管理局對新型靶向細胞凋亡調節藥物的核准增加預計將在預測期內推動全球細胞凋亡市場的發展。據世界衛生組織稱，未來 20 年癌症負擔預計將增加 70%。然而，與藥物開拓和臨床試驗相關的高成本可能會阻礙市場成長。從積極的一面來看，亞太和拉丁美洲等新興市場由於醫療成本不斷上升以及對優質醫療保健的需求，為市場參與者提供了利潤豐厚的機會。此外，對聯合治療和管道藥物的持續探索將在未來幾年繼續產生新的前景。
本研究的主要特點
本報告詳細分析了全球細胞凋亡市場，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、業績和策略等參數，介紹了全球細胞凋亡市場中的主要企業的概況。
主要企業包括雅培、羅氏、諾華、百時美施貴寶、默克和輝瑞。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球細胞凋亡市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球細胞凋亡市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章 市場動態、法規與趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第 4 章全球細胞凋亡市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球細胞凋亡市場，依應用分類，2019-2031
- 腫瘤學
- 神經退化性疾病
- 自體免疫疾病
- 心血管疾病
- 其他
第6章 全球細胞凋亡市場，依模式，2019-2031
- 細胞凋亡檢測
- 凋亡抗體
- 細胞凋亡抑制劑和誘導劑
第 7 章 全球細胞凋亡市場，依最終使用者分類，2019-2031
- 製藥和生物技術公司
- 學術研究所
- 合約研究組織
- 其他
第8章全球細胞凋亡市場，按地區，2019-2031
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- 公司簡介
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories
- GE Healthcare
- Becton, Dickinson and Company（BD）
- Promega Corporation
- Sartorius AG
- Abcam plc.
- Biotium
- Geno Technology
- BioTek Instruments
- Canvax
- Abnova
- Creative Bioarray
- PerkinElmer
- Danaher Corporation
- Bio-Techne
- GeneCopoeia, Inc.
- Takara Bio Inc.
- Bioss Antibodies
第10章分析師建議
第11章調查方法
- 參考
- 調查方法
The Global Apoptosis Market is estimated to be valued at USD 3.81 Billion in 2024 and is expected to reach USD 5.65 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 3.81 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 5.80% | 2031 Value Projection: | US$ 5.65 Bn |
Apoptosis, commonly known as programmed cell death, is a natural process in living organisms to remove unnecessary or damaged cells in a controlled manner. Dysregulation of apoptosis can lead to pathogenic conditions like cancer, autoimmune disorders, and neurodegenerative diseases. Therefore, research and development of new targeted therapeutics to modulate apoptosis for treatment of such diseases is contributing to the growth of this market. Advancements in understanding the molecular mechanisms of apoptosis and development of novel pathway inhibitors are expanding the applications and driving the demand for apoptosis modulating drugs globally.
Market Dynamics:
Rise in prevalence of cancer and other apoptosis related disorders, increasing R&D investments by pharmaceutical companies, and growing USFDA approvals for novel targeted apoptosis modulating drugs are some of the major factors projected to propel the global apoptosis market during the forecast period. According to WHO, cancer burden is expected to grow by 70% in the next two decades. However, high costs associated with drug development and clinical trials may hamper market growth. On the positive side, emerging markets such as Asia Pacific and Latin America offer lucrative opportunities for market players due to growing healthcare expenditure and demand for quality care in these regions. Furthermore, ongoing research on combination therapies and pipeline drugs will continue creating new prospects over the coming years.
Key features of the study:
This report provides in-depth analysis of the global apoptosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global apoptosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbot, Roche, Novartis, Bristol-Myers Squibb, Merck, and Pfizer
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global apoptosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global apoptosis market.
Detailed Segmentation-
- By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Oncology
- Neurodegenerative Diseases
- Autoimmune Disorders
- Cardiovascular Diseases
- Others
- By Modality Insights (Revenue, USD Bn, 2019 - 2031)
- Apoptosis Assays
- Apoptosis Antibodies
- Apoptosis Inhibitors and Inducers
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
- Ohers
- Regional Insights (Revenue, USD Bn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories
- GE Healthcare
- Becton, Dickinson and Company (BD)
- Promega Corporation
- Sartorius AG
- Abcam plc.
- Biotium
- Geno Technology
- BioTek Instruments
- Canvax
- Abnova
- Creative Bioarray
- PerkinElmer
- Danaher Corporation
- Bio-Techne
- GeneCopoeia, Inc.
- Takara Bio Inc.
- Bioss Antibodies
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Modality
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Apoptosis Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Apoptosis Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Neurodegenerative Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Autoimmune Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Apoptosis Market, By Modality, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Apoptosis Assays
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Apoptosis Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Apoptosis Inhibitors and Inducers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Apoptosis Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Academic and Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Apoptosis Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Merck KGaA
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GE Healthcare
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton, Dickinson and Company (BD)
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Promega Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sartorius AG
- Abcam plc.
- Biotium
- Geno Technology
- BioTek Instruments
- Canvax
- Abnova
- Creative Bioarray
- PerkinElmer
- Danaher Corporation
- Bio-Techne
- GeneCopoeia, Inc.
- Takara Bio Inc.
- Bioss Antibodies
- Merck KGaA
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. Research Methodology
- References
- Research Methodology
- About us and Sales Contact
